| Active Not Recruiting | Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic S Myelodysplastic Syndromes | Phase 3 | 2021-10-27 |
| Active Not Recruiting | Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in S Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 3 | 2021-04-30 |
| Completed | Emicizumab in Acquired Hemophilia A Hemophilia A, Acquired | Phase 2 | 2021-03-23 |
| Completed | Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suff Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2020-05-25 |
| Recruiting | Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML MDS, AML | Phase 2 | 2019-08-19 |
| Completed | ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy Aggressive Non-hodgkin Lymphoma (aNHL), Lymphoma, B-Cell, Lymphoma, T-Cell | Phase 2 | 2019-06-24 |
| Completed | Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome | Phase 2 | 2018-12-20 |
| Terminated | Study in Patients With Chronic Leukemia Leukemia, Myeloid, Chronic-Phase | Phase 2 | 2018-12-11 |
| Terminated | Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib Soft Tissue Sarcoma Adult | Phase 4 | 2018-11-02 |
| Completed | Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or R Refractory Multiple Myeloma | Phase 2 | 2018-09-20 |
| Completed | Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis Dermatitis, Atopic, Eczema, Atopic, Neurodermatitis, Atopic | Phase 2 | 2018-09-18 |
| Completed | EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations Iron-deficiency | — | 2018-01-16 |
| Completed | Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry Dyslipoproteinemias, Hypercholesterolemia, Familial, Familial Hypercholesterolemia - Homozygous | — | 2017-05-18 |
| Completed | Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | — | 2017-02-02 |
| Terminated | Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette Endothelial Function | — | 2017-01-09 |
| Completed | Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO) Primary Immunodeficiency, Secondary Immune Deficiency | — | 2016-12-22 |
| Terminated | Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | Phase 2 | 2016-07-01 |
| Completed | Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Diseas Parkinson's Disease | — | 2016-06-01 |
| Completed | INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis Superficial Vein Thrombosis | — | 2016-04-14 |
| Completed | Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry Non-valvular Atrial Fibrillation (NVAF), Chronic Kidney Disease (CKD) | — | 2016-04-01 |
| Terminated | Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Dia Diabetes Mellitus Type 2 | Phase 4 | 2015-09-01 |
| Completed | Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Type 2 Diabetic Patients | Phase 3 | 2015-04-01 |
| Completed | Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products Acne Vulgaris | Phase 4 | 2015-02-01 |
| Completed | Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers Diabetic Macular Edema | — | 2015-02-01 |
| Completed | Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma Soft Tissue Sarcoma | — | 2014-09-01 |
| Completed | Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type Diabetes Mellitus Type II | Phase 3 | 2014-08-01 |
| Unknown | Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Ede Diabetic Macular Edema | Phase 4 | 2014-04-30 |
| Completed | Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery MDS and AML Prior to Allogeneic SCT | — | 2012-12-01 |
| Completed | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency Type 2 Diabetes Mellitus, Iron Deficiency | Phase 3 | 2012-08-01 |
| Completed | Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients Diabetes Mellitus Type 2 | — | 2012-06-01 |
| Completed | Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux Superficial Vein Thrombosis | Phase 3 | 2012-04-01 |
| Unknown | Register for New Oral Anticoagulants Anticoagulation Treatment | — | 2011-11-01 |
| Terminated | Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia Diabetic Foot, Critical Limb Ischemia | Phase 3 | 2011-06-01 |
| Terminated | Immunoadsorption in Patients With Severe Systemic Sclerosis Systemic Scleroderma | N/A | 2011-04-01 |
| Terminated | Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia Type 2 Diabetes Mellitus, Diabetic Foot, Critical Limb Ischemia | — | 2010-06-01 |
| Completed | Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects Type 2 Diabetes | Phase 4 | 2009-03-01 |
| Completed | Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome Metabolic Syndrome, Dyslipidaemia | Phase 3 | 2007-01-01 |
| Completed | AI(I)DA Acarbose and the Subclinical Inflammation Type 2 Diabetes Mellitus, Subclinical Inflammation | Phase 3 | 2005-01-01 |
| Completed | Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial Metabolic Syndrome | Phase 3 | — |